<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>plasma metabolites distinguishes colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>plasma metabolites</strong>
  <span class="pred">&mdash;distinguishes&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">UNKNOWN:plasma metabolites &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 121.31<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.5 (Curated) &times; log&#8322;(1+1) = 0.50<br>Incoming citations: 60 &rarr; score 121.31</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1002/ijc.32146">10.1002/ijc.32146</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 60 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>30</span><span class="cite-subtotal">&middot; +63.44</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">taurine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.64</span><a href="../claim/c46d79d6a72d684c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+6.00</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">taurine — decreases → colorectal cancer liver metastasis</span><span class="cite-claim-weight">+1.00</span><a href="../claim/085d425052ce8882.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine (diacyl) C32:0 — increases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.50</span><a href="../claim/20b11e9574370b5b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Citrulline — decreases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d618f8e55738d49d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (acyl) C17:0 — decreases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.50</span><a href="../claim/324328b6b1b7ac70.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PS(P-36:1) — is_biomarker_for → Colon Cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/e5580b1247bed017.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PS(P-38:3) — is_biomarker_for → Colon Cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/3b7808708f4549b0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">PS(P-40:5) — is_biomarker_for → Colon Cancer</span><span class="cite-claim-weight">+10.00</span><a href="../claim/9e931b612f647350.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Colon Cancer — decreases → Glyceronephosphate O-acyltransferase (GNPAT)</span><span class="cite-claim-weight">+10.00</span><a href="../claim/078a3491e2812d97.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">amino acids (plasma) — decreases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/99a0e9dbf318bdf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholines — decreases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/dd2bcb86c633398a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">diacylphosphatidylcholines — decreases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/558227bf016159c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acyl-alkylphosphatidylcholines — decreases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8fd3765ebc529aa9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelins — decreases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b402ffd8d62f9753.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acylcarnitines — increases → total fatigue</span><span class="cite-claim-weight">+0.50</span><a href="../claim/ac0e29ef3f10864d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">amino acids (plasma) — decreases → fatigue severity</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d3f35386e474ff9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lysophosphatidylcholines — decreases → fatigue severity</span><span class="cite-claim-weight">+0.50</span><a href="../claim/9bf841eec1d3e3d2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">acylcarnitines — increases → fatigue severity</span><span class="cite-claim-weight">+0.50</span><a href="../claim/78c6dbc7679749e7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">brominated trihalomethanes — correlates_with → nicotinamide metabolism</span><span class="cite-claim-weight">+0.50</span><a href="../claim/0d614be134891151.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">total trihalomethanes — correlates_with → cytochrome P-450 metabolism</span><span class="cite-claim-weight">+0.50</span><a href="../claim/984990d22170d58d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">trihalomethanes — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5283afcb749dad9a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">nitrate — correlates_with → colorectal cancer risk</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a69f50298d0f77a8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">trihalomethanes — correlates_with → nicotinamide metabolism</span><span class="cite-claim-weight">+0.50</span><a href="../claim/43e186621b8bf165.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingolipid metabolism — is_biomarker_for → Colorectal adenoma progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b346e1df6cfc5ffd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">LASSO-selected serum metabolites (57 variables) — distinguishes → Advanced Adenoma / CRC vs NC / Non-Advanced Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/dcd91957516ba626.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:93px"></span><span>28</span><span class="cite-subtotal">&middot; +57.27</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+5.57</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Taurine — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/33e4ff3e124bfc3e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingomyelin C26:0 — distinguishes → Colorectal Cancer Stage III vs Stage I</span><span class="cite-claim-weight">+0.60</span><a href="../claim/e2d7370d34a65af4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingomyelin C26:0 — decreases → Colorectal Cancer Stage III</span><span class="cite-claim-weight">+0.60</span><a href="../claim/78d8e6ce851ed878.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingomyelin C18:0 — increases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bb969a74fbb35f1c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Histidine — decreases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.60</span><a href="../claim/0683202f1c47fc32.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine (diacyl) C34:4 — decreases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6d2cc809b3cf541a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine (acyl-alkyl) C40:1 — decreases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b740547d5681e3e9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (acyl) C16:0 — decreases → Colorectal Cancer Stage IV</span><span class="cite-claim-weight">+1.20</span><a href="../claim/09e39257374f7286.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Plasmalogens (PS(P-36:1), PS(P-38:3), PS(P-40:5)) — distinguishes → Colon Cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/fb2804c44224fa03.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Ether lipids — distinguishes → Colon Cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/b736c0400ebdde6e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Plasma lipid profile — distinguishes → Colon Cancer</span><span class="cite-claim-weight">+12.00</span><a href="../claim/cc03a1b39972110e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites (138 metabolites panel) — is_biomarker_for → fatigue severity in colorectal cancer survivors</span><span class="cite-claim-weight">+0.60</span><a href="../claim/18a250f82c93c1b8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites (138 metabolites panel) — correlates_with → reduced motivation (fatigue subdomain)</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b61c440ca56b11e9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — correlates_with → persistent fatigue in colorectal cancer survivors</span><span class="cite-claim-weight">+0.60</span><a href="../claim/61130e0fec38a3ad.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">nitrate — correlates_with → tyrosine metabolism</span><span class="cite-claim-weight">+0.60</span><a href="../claim/523a1c782fd8dd84.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">nitrate — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/dca0108befbfc888.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolomic features (568) — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b669179bd3946164.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">chloroform — correlates_with → colorectal cancer risk</span><span class="cite-claim-weight">+0.60</span><a href="../claim/e604cdf95d8a60b1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolite panel (random forest model) — distinguishes → Advanced Adenoma / Colorectal Cancer vs NC/NAA</span><span class="cite-claim-weight">+0.60</span><a href="../claim/62876bbe01a7c696.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolites (33 differential) — distinguishes → Advanced Adenoma vs Non-Advanced Adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5b9b3587fa157624.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Glycerophospholipid metabolism — is_biomarker_for → Colorectal adenoma progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/c20a2c04aee99d51.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Caffeine metabolism — is_biomarker_for → Colorectal adenoma progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/86361b6ef72179ae.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolite composition — distinguishes → Colorectal cancer vs Healthy controls / Non-Advanced Adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/2963ed71769b9647.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:7px"></span><span>2</span><span class="cite-subtotal">&middot; +0.60</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.30</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">chloroform — correlates_with → nicotinamide metabolism</span><span class="cite-claim-weight">+0.30</span><a href="../claim/8cda5312cf884672.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>25bc564792710f83</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:plasma metabolites">UNKNOWN:plasma metabolites</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
